MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ijid.2024.107172

Медицинская библиотека · International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2024

Ciprofloxacin versus levofloxacin prophylaxis in hematopoietic stem cell transplantation: A randomized trial.

Farhan Shatha, Mazur Izabela, Hartzell Susan, Xie Peter, Neme Klodiana, German Angela, Mikulandric Nancy, Patel Kunj, Wu Min, Kortam Neda, Yaseen Aseel, Sweidan Aroob, Latack Katie, Emole Josephine, Peres Edward, Abidi Muneer H, Ramesh Mayur

Клиническое исследование II фазыСравнительное исследованиеСтатьяРандомизированное исследованиеПеревод пока не подготовлен

Аннотация

OBJECTIVES

We aimed to assess whether there is a difference between ciprofloxacin and levofloxacin as prophylaxis in hematopoietic stem cell transplant (SCT) recipients.

METHODS

This is a prospective, randomized trial in patients receiving SCT at Henry Ford Health in the United States of America. We randomly assigned patients (1:1) to receive ciprofloxacin or levofloxacin. The primary outcome was incidence of bloodstream bacterial infections (BSI) up to day 60 after SCT.

RESULTS

Between June 4, 2018, and May 23, 2022, we randomly assigned 308 consecutive patients to receive ciprofloxacin (154 patients) or levofloxacin (154 patients). BSI was similar in both the ciprofloxacin and levofloxacin groups (18 [11.7%] vs 18 [11.7%]). Pneumonia was more frequent in the ciprofloxacin group compared to the levofloxacin group (18 [18%] vs 7 [23%]; relative risk 2.57, 95% CI 1.11-5.98; p = 0.028). There were no differences in neutrophil engraftment, fever, Clostridium difficile infection, relapse incidence, overall survival, nonrelapse mortality, length of stay post-SCT, or intensive care unit admission.

CONCLUSION

Although both prophylaxis regimens demonstrated the same efficacy in SCT recipients, levofloxacin prophylaxis led to less pneumonia in the first 60 days post-SCT.

TRIAL REGISTRATION: This study is registered on ClinicalTrials.gov, NCT03850379.

Для цитирования: Farhan Shatha, Mazur Izabela, Hartzell Susan, Xie Peter, Neme Klodiana, German Angela, Mikulandric Nancy, Patel Kunj, Wu Min, Kortam Neda, Yaseen Aseel, Sweidan Aroob, Latack Katie, Emole Josephine, Peres Edward, Abidi Muneer H, Ramesh Mayur. Ciprofloxacin versus levofloxacin prophylaxis in hematopoietic stem cell transplantation: A randomized trial.. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2024. DOI: 10.1016/j.ijid.2024.107172.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.